⌘K

Login Start Free

Home/Filings/4/A/0001161697-09-001053

4/A//SEC Filing

Catalyst Pharmaceutical Partners, Inc. 4/A

Accession 0001161697-09-001053

$CPRXCIK 0001369568operating

View on SEC.gov Company Profile

Filed

Oct 21, 8:00 PM ET

Accepted

Oct 22, 7:07 PM ET

Size

11.9 KB

Accession

0001161697-09-001053

Insider Transaction Report

Form 4/AAmended

Period: 2009-10-20

Catalyst Pharmaceutical Partners, Inc.CPRX

V.P., Treasurer & CFO

Transactions

Expiration (Short)
Options to purchase common stock
2009-10-20−145,922→ 306,842 total
Exercise: $2.98Exp: 2010-03-04→ Common Stock (145,922 underlying)
Award
Options to purchase common stock
2009-10-20+41,666→ 348,508 total
Exercise: $0.90From: 2009-10-20Exp: 2014-10-20→ Common Stock (41,666 underlying)
Award
Options to purchase common stock
2009-10-20+41,667→ 390,175 total
Exercise: $0.90From: 2010-10-20Exp: 2014-10-20→ Common Stock (41,667 underlying)
Award
Options to purchase common stock
2009-10-20+41,667→ 431,842 total
Exercise: $0.90From: 2011-10-20Exp: 2014-10-20→ Common Stock (41,667 underlying)

Footnotes (3)

[F1]Options were cancelled pursuant to the above-described grant.
[F2]Current.
[F3]This Form 4 has been amended to correct an error in the price of the derivative security.

Documents

1 file

4
form4_ex.xml
FORM 4/A1 FOR 10-20-2009

Issuer

Catalyst Pharmaceutical Partners, Inc.

CIK 0001369568

Entity typeoperating

IncorporatedDE

Related Parties

1

filerCIK 0001369568

Filing Metadata

Form type: 4/A
Filed: Oct 21, 8:00 PM ET
Accepted: Oct 22, 7:07 PM ET
Size: 11.9 KB

View on SEC.gov